Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-10-2020 | Cataract | Cataract

Efficacy of intracameral preservative-free triamcinolone acetonide in pediatric cataract surgery: a meta-analysis

Authors: Yu-yu Chou, Bi-lei Zhang, Lin-yang Gan, Jin Ma, Yong Zhong

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2020

Abstract

Purpose

The aim of this study is to evaluate the efficacy of intracameral preservative-free triamcinolone acetonide (TA) on reducing inflammatory reactions after pediatric cataract surgery.

Methods

Researches were comprehensively searched in PubMed, Embase, and the Cochrane Central Register of Controlled Trials up to 30 November, 2019. Data of interest were extracted and analyzed by Review Manager 5.2. The primary outcome was cell deposits. The secondary outcomes included posterior synechias, fibrinous anterior chamber reaction, visual axis obscuration, and posterior capsule opacification. The odds ratio (OR), weight mean difference (WMD), and their 95% confidence intervals (95% CI) were used to assess the strength of the association.

Results

In total, 45 articles were obtained. Finally, 5 studies with a total of 308 eyes were enrolled in this meta-analysis. Among these, 134 eyes underwent intracameral TA treatment and 174 eyes did not. In intracameral TA treatment group, the incidence of cell deposits (OR = 0.35, 95% CI 0.16–0.76, P = 0.008), posterior synechias (OR = 0.44, 95% CI 0.23–0.86, P = 0.02), and fibrinous anterior chamber reaction (OR = 0.12, 95% CI 0.01–1.05, P = 0.05) were lower compared to those in patients without intracameral TA treatment. Meanwhile, the incidence of visual axis obscuration (OR = 0.10, 95% CI 0.01–0.85, P = 0.04) and posterior capsule opacification (OR = 0.09, 95% CI 0.02–0.55, P = 0.009) were also reduced significantly. The intraocular pressure (IOP) was evaluated at the first month postoperatively (WMD = 0.84 mmHg, 95% CI 0.14–1.53, P = 0.02), but within the normal range. There was no difference of IOP between two groups at 6 months or above after operation (P = 0.93).

Conclusions

The intracameral preservative-free TA in pediatric cataract surgery contributed to much less inflammatory reaction with the normal IOP range.

Sheeladevi S, Lawrenson JG, Fielder AR, Suttle CM (2016) Global prevalence of childhood cataract: a systematic review. Eye (Lond) 30:1160–1169. https://doi.org/10.1038/eye.2016.156CrossRef

Medsinge A, Nischal KK (2015) Pediatric cataract: Challenges and future directions. Clin Ophthalmol 9:77–90. https://doi.org/10.2147/OPTH.S59009CrossRefPubMedPubMedCentral

Wong IB, Sukthankar VD, Cortina-Borja M, Nischal KK (2009) Incidence of early-onset glaucoma after infant cataract extraction with and without intraocular lens implantation. Br J Ophthalmol 93:1200–1203. https://doi.org/10.1136/bjo.2008.155200CrossRefPubMed

Basti S, Ravishankar U, Gupta S (1996) Results of a prospective evaluation of three methods of management of pediatric cataracts. Ophthalmology 103:713–720. https://doi.org/10.1016/s0161-6420(96)30624-6CrossRefPubMed

Ram J, Brar GS, Kaushik S, Gupta A, Gupta A (2003) Role of posterior capsulotomy with vitrectomy and intraocular lens design and material in reducing posterior capsule opacification after pediatric cataract surgery. J Cataract Refract Surg 29:1579–1584. https://doi.org/10.1016/s0886-3350(03)00231-1CrossRefPubMed

Yamakiri K, Uchino E, Kimura K, Sakamoto T (2004) Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery. Am J Ophthalmol 138:650–652. https://doi.org/10.1016/j.ajo.2004.05.033CrossRefPubMed

Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554–555. https://doi.org/10.1097/00006982-200005000-00024CrossRefPubMed

Shah SK, Vasavada V, Praveen MR, Vasavada AR, Trivedi RH, Dixit NV (2009) Triamcinolone-assisted vitrectomy in pediatric cataract surgery. J Cataract Refract Surg 35:230–232. https://doi.org/10.1016/j.jcrs.2008.10.037CrossRefPubMed

Negi AK, Browning AC, Vernon SA (2006) Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J Cataract Refract Surg 32:468–474. https://doi.org/10.1016/j.jcrs.2005.12.102CrossRefPubMed

10.

Cleary CA, Lanigan B, O'Keeffe M (2010) Intracameral triamcinolone acetonide after pediatric cataract surgery. J Cataract Refract Surg 36:1676–1681. https://doi.org/10.1016/j.jcrs.2010.04.038CrossRefPubMed

11.

Smithen LM, Ober MD, Maranan L, Spaide RF (2004) Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138:740–743. https://doi.org/10.1016/j.ajo.2004.06.067CrossRefPubMed

12.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 62:1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005CrossRefPubMed

13.

Allam G, Ellakkany R, Ellayeh A, Mohsen T, Abouelkheir HE, Gaafar W (2018) Outcome of pediatric cataract surgery with intraocular injection of triamcinolone acetonide: Randomized controlled trial. Eur J Ophthalmol 28:633–638. https://doi.org/10.1177/1120672117754168CrossRefPubMed

14.

Gupta R, Ram J, Sukhija J, Singh R (2014) Outcome of paediatric cataract surgery with primary posterior capsulotomy and anterior vitrectomy using intra-operative preservative-free triamcinolone acetonide. Acta Ophthalmol 92:e358–e361. https://doi.org/10.1111/aos.12375CrossRefPubMed

15.

Ventura MC, Ventura BV, Ventura CV, Ventura LO, Arantes TE, Nose W (2014) Outcomes of congenital cataract surgery: Intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. J Cataract Refract Surg 40:601–608. https://doi.org/10.1016/j.jcrs.2013.09.011CrossRefPubMed

16.

Mohamed TA, Soliman W, Fathalla AM (2016) Effect of intracameral triamcinolone acetonide on postoperative intraocular inflammation in pediatric traumatic cataract. Eur J Ophthalmol 26:114–117. https://doi.org/10.5301/ejo.5000648CrossRefPubMed

17.

Dixit NV, Shah SK, Vasavada V, Vasavada VA, Praveen MR, Vasavada AR, Trivedi RH (2010) Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes. J Cataract Refract Surg 36:1494–1498. https://doi.org/10.1016/j.jcrs.2010.03.040CrossRefPubMed

18.

Van Looveren J, Ni DS, Godts D, Bakker E, De Veuster I, Mathysen DG, Tassignon MJ (2015) Pediatric bag-in-the-lens intraocular lens implantation: long-term follow-up. J Cataract Refract Surg 41:1685–1692. https://doi.org/10.1016/j.jcrs.2014.12.057CrossRefPubMed

19.

Gasper C, Trivedi RH, Wilson ME (2016) Complications of pediatric cataract surgery. Dev Ophthalmol 57:69–84. https://doi.org/10.1159/000442502CrossRefPubMed

20.

Karalezli A, Borazan M, Akova YA (2008) Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol 86:183–187. https://doi.org/10.1111/j.1600-0420.2007.01114.xCrossRefPubMed

21.

Steven DW, Alaghband P, Lim KS (2018) Preservatives in glaucoma medication. Br J Ophthalmol 102:1497–1503. https://doi.org/10.1136/bjophthalmol-2017-311544CrossRefPubMed

22.

Yu SH, Drucker AM, Lebwohl M, Silverberg JI (2018) A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol 78:733–740. https://doi.org/10.1016/j.jaad.2017.09.074CrossRefPubMed

23.

Sakamoto T, Ishibashi T (2009) Visualizing vitreous in vitrectomy by triamcinolone. Graefes Arch Clin Exp Ophthalmol 247:1153–1163. https://doi.org/10.1007/s00417-009-1118-2CrossRefPubMed

24.

Kaynak S, Celik L, Kocak N, Oner FH, Kaynak T, Cingil G (2006) Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation. J Cataract Refract Surg 32:56–59. https://doi.org/10.1016/j.jcrs.2005.10.028CrossRefPubMed

25.

Li J, Heinz C, Zurek-Imhoff B, Heiligenhaus A (2006) Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis. J Cataract Refract Surg 32:1535–1539. https://doi.org/10.1016/j.jcrs.2006.04.018CrossRefPubMed

26.

Tao Y, Jonas JB (2011) Intravitreal triamcinolone. Ophthalmologica 225:1–20. https://doi.org/10.1159/000317909CrossRefPubMed

27.

Philip SS, Braganza AD, Rebekah GJ (2019) Comparison of a single intraoperative posterior sub-Tenon's capsule triamcinolone acetonide injection versus topical steroids for treatment of postcataract surgery inflammation in children. Oman J Ophthalmol 12:25–30. https://doi.org/10.4103/ojo.OJO_147_2017CrossRefPubMedPubMedCentral

28.

Sharma N, Pushker N, Dada T, Vajpayee RB, Dada VK (1999) Complications of pediatric cataract surgery and intraocular lens implantation. J Cataract Refract Surg 25:1585–1588CrossRefPubMed

29.

Hosal BM, Biglan AW (2002) Risk factors for secondary membrane formation after removal of pediatric cataract. J Cataract Refract Surg 28:302–309. https://doi.org/10.1016/s0886-3350(01)01028-8CrossRefPubMed

30.

Tsai TH, Tsai CY, Huang JY, Hu FR (2017) Outcomes of pediatric cataract surgery with triamcinolone-assisted vitrectomy. J Formos Med Assoc 116:940–945. https://doi.org/10.1016/j.jfma.2017.01.009CrossRefPubMed

31.

Jermak CM, Dellacroce JT, Heffez J, Peyman GA (2007) Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 52:503–522. https://doi.org/10.1016/j.survophthal.2007.06.004CrossRefPubMed

32.

Inatani M, Iwao K, Kawaji T, Hirano Y, Ogura Y, Hirooka K, Shiraga F, Nakanishi Y, Yamamoto H, Negi A, Shimonagano Y, Sakamoto T, Shima C, Matsumura M, Tanihara H (2008) Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study. Am J Ophthalmol 145:676–681. https://doi.org/10.1016/j.ajo.2007.12.010CrossRefPubMed

33.

Wang B, Dong N, Xu B, Liu J, Xiao L (2013) Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy. J Cataract Refract Surg 39:1691–1697. https://doi.org/10.1016/j.jcrs.2013.04.042CrossRefPubMed

34.

Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791–796. https://doi.org/10.1016/s0002-9394(03)00483-5CrossRefPubMed

35.

Mishra C, Lalitha P, Rameshkumar G, Agrawal R, Balne PK, Iswarya M, Kannan NB, Ramasamy K (2018) Incidence of endophthalmitis after intravitreal injections: Risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm 26:559–568. https://doi.org/10.1080/09273948.2018.1430238CrossRefPubMed

36.

Jonas JB, Kreissig I, Spandau UH, Harder B (2006) Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am J Ophthalmol 141:579–580. https://doi.org/10.1016/j.ajo.2005.10.007CrossRefPubMed

37.

Gills JP, Gills P (2005) Effect of intracameral triamcinolone to control inflammation following cataract surgery. J Cataract Refract Surg 31:1670–1671. https://doi.org/10.1016/j.jcrs.2005.07.023CrossRefPubMed

Title: Efficacy of intracameral preservative-free triamcinolone acetonide in pediatric cataract surgery: a meta-analysis
Authors: Yu-yu Chou
Bi-lei Zhang
Lin-yang Gan
Jin Ma
Yong Zhong
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Cataract
Vitrectomy
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2020
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-020-04765-x

At a glance: The STEP trials

Springer Medicine

Efficacy of intracameral preservative-free triamcinolone acetonide in pediatric cataract surgery: a meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2020

Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy

Frequency of cataract surgery and its impact on visual function—results from the German Gutenberg Health Study

What COVID-19 has taught us: lessons from around the globe

Airborne pathogen projection during ophthalmic examination

Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber’s hereditary optic neuropathy

Disease-causing mutations associated with bestrophinopathies promote apoptosis in retinal pigment epithelium cells